Viking Global Investors
BLUE

Viking Global Investors’s bluebird bio BLUE Stock Holding History

Viking Global Investors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-47,521
Closed -$52.7M – 71
2015
Q3 		$52.7M Buy
+47,521
New +$86.7M 0.2% 52

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Viking Global Investors's BLUE Position: Q4 2015 in Review

Viking Global Investors sold out of bluebird bio (BLUE) in Q4 2015, closing a stake of 47,521 shares — an estimated $52.7M sold.

Viking Global Investors first reported a position in BLUE in Q3 2015 and held it in 1 quarter. The position peaked at $52.7M in Q3 2015. 193 funds tracked by Wall St. Rank hold BLUE as of Q4 2015.

  • Viking Global Investors reported no remaining bluebird bio position as of Q4 2015 after selling out during the quarter.
  • Viking Global Investors sold 47,521 bluebird bio shares in Q4 2015, an estimated $52.7M.
  • Viking Global Investors first reported a position in bluebird bio in Q3 2015 and held it in 1 quarter.
  • Viking Global Investors's bluebird bio position peaked at $52.7M in Q3 2015.
  • 193 funds tracked by Wall St. Rank held bluebird bio as of Q4 2015.

Based on Viking Global Investors's 13F filing for Q4 2015, filed 16 Feb 2016.